ATF1 and hepatocellular carcinoma: In hepatocellular carcinoma cells, AMPK acts upstream to drive the sAC–cAMP–PKA–CREB/ATF1 cascade, as shown in aspirin-treated models where AMPK activation increases cAMP and PKA activity, and AMPK knockdown abolishes this effect [42].